InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+2.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Ball Jack, Director. Director active across 1 company, notably Cytek Biosciences, Inc.. In total, 5 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €87k. Activity tracked since 22 July 2021. The latest transaction was filed on 29 November 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
43,973 sharesCommon StockSEC:0001873083-26-000001:0
10,666 shares@ US$0.404.3% of flowCommon StockSEC:0001209191-22-059113:0
16,000 shares@ US$0.406.4% of flowCommon StockSEC:0001209191-22-057368:0
3,000 shares@ US$17.000.0099% mcap50.0% of flowCommon StockSEC:0001209191-21-048388:0
Ideal exit: 18 Apr 2022 (T+270)
3,000 shares@ US$17.0044.7% of flowCommon StockSEC:0001209191-21-048388
Ideal exit: 18 Apr 2022 (T+270)
5 of 5 declarations
About Ball Jack
Ball Jack is a Board Member at Cytek Biosciences, Inc. He contributes to the governance and strategy of the company, bringing his expertise in the life sciences field. His role is crucial in guiding decisions that affect the future of Cytek Biosciences.
